FUM — Futura Medical Cashflow Statement
0.000.00%
- £6.63m
- £2.94m
- £13.93m
Annual cashflow statement for Futura Medical, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.93 | -5.87 | -6.87 | -6.89 | 1.29 |
| Depreciation | |||||
| Non-Cash Items | 0.148 | 0.182 | 0.672 | 2.7 | 1.98 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.79 | 1.79 | 0.399 | 4.63 | -3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.54 | -3.87 | -5.78 | 0.57 | 0.391 |
| Capital Expenditures | -0.008 | -0.42 | -0.741 | -1.51 | -1.73 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.001 | 0 | — | 0.072 | 0.047 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.007 | -0.42 | -0.741 | -1.43 | -1.68 |
| Financing Cash Flow Items | -0.212 | -0.672 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 3.06 | 13.6 | 0.17 | 4.55 | 0.171 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.49 | 9.35 | -6.35 | 3.69 | -1.12 |